Kynamro FDA Approved Drugs
KYNAMRO [Mipomersen SodiumC230H305N67O122P19S1919Na]
RX
- 200mg/ml (200mg/ml) (subcutaneous solution)
Kastle Theraps LlcJan 29, 2013
- Adjunctive therapy to lipid-lowering medications and diet to reduce low density lipoprotein-cholesterol, apolipoprotein b, total cholesterol, and non-high density lipoprotein cholesterol in pts with homozygous familial hypercholesterolemia.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.